Moreover, a correlation between breast cancer cell motility and TG2 expression and localization has been demonstrated: exposure to doxorubicin, a chemotherapeutic drug, increased TG2 levels, thus triggering the EMT and supporting cell motility due to an interaction between TG2 and vimentin. The gene discussed is TGM2; the disease is breast carcinoma.